Racagni, Giorgio

Brain-derived neurotrophic factor: a bridge between inflammation and neuroplasticity

Calabrese, F., Rossetti, A. C., Racagni, G., Gass, P., Riva, M. A., & Molteni, R. (2014) · Frontiers in Cellular Neuroscience

Nerve injury and regenerationNeuroinflammation and Neurodegeneration Mechanisms

Cited by 482

Postnatal repeated maternal deprivation produces age-dependent changes of brain-derived neurotrophic factor expression in selected rat brain regions

Roceri, M., Cirulli, F., Pessina, C., Peretto, P., Racagni, G., & Riva, M. A. (2004) · Biological Psychiatry

Stress Responses and CortisolNerve injury and regeneration

Cited by 317

Signaling Pathways Regulating Gene Expression, Neuroplasticity, and Neurotrophic Mechanisms in the Action of Antidepressants: A Critical Overview

Tardito, D., Perez, J., Tiraboschi, E., Musazzi, L., Racagni, G., & Popoli, M. (2006) · Pharmacological Reviews

Treatment of Major DepressionNeurotransmitter Receptor Influence on Behavior

Cited by 303

Glucocorticoid Receptor and FKBP5 Expression Is Altered Following Exposure to Chronic Stress: Modulation by Antidepressant Treatment

Guidotti, G., Calabrese, F., Anacker, C., Racagni, G., Pariante, C. M., & Riva, M. A. (2013) · Neuropsychopharmacology

Stress Responses and CortisolTreatment of Major Depression

Cited by 200

Cellular and molecular mechanisms in the long-term action of antidepressants.

Racagni, G., & Popoli, M. (2008) · Dialogues in Clinical Neuroscience

Treatment of Major DepressionNeuroscience and Neuropharmacology Research

Cited by 192

Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment

Brunello, N., den Boer, J. A., Judd, L. L., Kasper, S., Kelsey, J. E., Lader, M., Lecrubier, Y., Lepine, J. P., Lydiard, R. B., Mendlewicz, J., et al. (2000) · Journal of Affective Disorders

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesSchizophrenia research and treatment

Cited by 153

Stress and corticosterone increase the readily releasable pool of glutamate vesicles in synaptic terminals of prefrontal and frontal cortex

Treccani, G., Musazzi, L., Perego, C., Milanese, M., Nava, N., Bonifacino, T., Lamanna, J., Malgaroli, A., Drago, F., Racagni, G., et al. (2014) · Molecular Psychiatry

Neuroscience and Neuropharmacology ResearchStress Responses and Cortisol

Cited by 133

Chronic treatment with fluoxetine up-regulates cellular BDNF mRNA expression in rat dopaminergic regions

Molteni, R., Calabrese, F., Bedogni, F., Tongiorgi, E., Fumagalli, F., Racagni, G., & Andrea Riva, M. (2006) · The International Journal of Neuropsychopharmacology

Treatment of Major DepressionNeurotransmitter Receptor Influence on Behavior

Cited by 132

Stress-Induced Changes of Hippocampal NMDA Receptors: Modulation by Duloxetine Treatment

Calabrese, F., Guidotti, G., Molteni, R., Racagni, G., Mancini, M., & Riva, M. A. (2012) · PLoS ONE

Treatment of Major DepressionNeuroscience and Neuropharmacology Research

Cited by 107

Modulation of neuronal plasticity following chronic concomitant administration of the novel antipsychotic lurasidone with the mood stabilizer valproic acid

Calabrese, F., Luoni, A., Guidotti, G., Racagni, G., Fumagalli, F., & Riva, M. A. (2013) · Psychopharmacology

Schizophrenia research and treatmentTreatment of Major Depression

Cited by 43

Changes in nitric oxide metabolite levels in stimulated substantia nigra neurons

Zecca, L., Fariello, R. G., Galimberti, M., Racagni, G., & Ambrosini, A. (1997) · NeuroReport

Nitric Oxide and Endothelin EffectsNeuroscience and Neuropharmacology Research

Cited by 11

Functional impairment in patients with major depression in clinical remission: results from the VIVAL-D-Rem, a nationwide, naturalistic, cross-sectional survey

Sacchetti, E., Frank, E., Siracusano, A., Racagni, G., Vita, A., & Turrina, C. (2015) · International Clinical Psychopharmacology

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 11